Description: Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People's Republic of China and internationally. The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, medical instruments, pharmaceutical products, medical equipment, and healthcare products; and research and development, production, and sale of beverages, food, healthcare products, and other products; and production and sale of pre-packaged food, dairy products, etc., as well as offers herbal tea, tablets, capsules, lozenges, tortoise herb jelly, etc. In addition, the company invests in health industry, such as medical services, health management, health maintenance, elderly care, etc.; and provides leasing and commercial, health, advertising, loading offloading, and warehouse services. It operates through retail chain pharmacy stores and retail stores. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.
Home Page: www.gybys.com.cn
No. 45, Shamian North Street
Guangzhou,
510130
China
Phone:
86 20 6628 1218
Officers
| Name | Title |
|---|---|
| Mr. Hong Li | GM & Executive Director |
| Ms. Ning Cheng CPA | Executive Vice Chairman |
| Mr. Jun Yang | Executive Vice Chairman |
| Mr. Changhai Wu | Deputy GM & Executive Director |
| Ms. Juyan Liu | Executive Director |
| Ms. Haoshan Zheng | Deputy GM & Director of Business Administration Department |
| Ms. Xuezhen Huang | Secretary |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 7.8519 |
| Price-to-Book MRQ: | 0.7314 |
| Price-to-Sales TTM: | 0.0753 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 28048 |